Abiopharma

Neurocrine Biosciences Presents New Post-Hoc Data Analyses from KINECT®-HD Study Demonstrating Significant Reduction in Disease Burden with INGREZZA® (valbenazine) Capsules for Huntingtons Disease Chorea

Results of Annual General Meeting

Avantor, Inc. - Avantor® to Host Second Quarter 2025 Earnings Call on Friday, August 1, 2025

Xpres Spa Named One of Yelp’s Most Loved Airport Brands

Avantor® to Host Second Quarter 2025 Earnings Call on Friday, August 1, 2025

Ainos and ASE Technology Holding Broaden Strategic Partnership to Target Deploy Up to 15,000 AI Nose Across Key Sites

Lyra Therapeutics Announces Up to Approximately $15 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

Ultragenyx Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome

Calidi Biotherapeutics - Calidi Biotherapeutics Announces Shareholder Letter from CEO

Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer